Stay updated on Ixekizumab Delivery in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab Delivery in Psoriasis Clinical Trial page.

Latest updates to the Ixekizumab Delivery in Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.9%
- Check8 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check30 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check59 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
Stay in the know with updates to Ixekizumab Delivery in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab Delivery in Psoriasis Clinical Trial page.